BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23828278)

  • 21. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease.
    Szczepański T; Langerak AW; Wolvers-Tettero IL; Ossenkoppele GJ; Verhoef G; Stul M; Petersen EJ; de Bruijn MA; van't Veer MB; van Dongen JJ
    Leukemia; 1998 Jul; 12(7):1081-8. PubMed ID: 9665194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH.
    Wu D; Emerson RO; Sherwood A; Loh ML; Angiolillo A; Howie B; Vogt J; Rieder M; Kirsch I; Carlson C; Williamson D; Wood BL; Robins H
    Clin Cancer Res; 2014 Sep; 20(17):4540-8. PubMed ID: 24970842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
    van der Velden VH; Szczepanski T; Wijkhuijs JM; Hart PG; Hoogeveen PG; Hop WC; van Wering ER; van Dongen JJ
    Leukemia; 2003 Sep; 17(9):1834-44. PubMed ID: 12970784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting.
    Lopez M; Lemoine FM; Firat H; Fouillard L; Laporte JP; Lesage S; Isnard F; Stachowiak J; Ferrer-Le Coeur F; Morel P; Najman A; Douay L; Gorin NC
    Blood; 1997 Oct; 90(7):2830-8. PubMed ID: 9326252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
    Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
    Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum BCL2/IGH DNA in follicular lymphoma patients: a minimal residual disease marker.
    Gocke CD; Kopreski MS; Benko FA; Sternas L; Kwak LW
    Leuk Lymphoma; 2000 Sep; 39(1-2):165-72. PubMed ID: 10975396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes.
    Linke B; Bolz I; Fayyazi A; von Hofen M; Pott C; Bertram J; Hiddemann W; Kneba M
    Leukemia; 1997 Jul; 11(7):1055-62. PubMed ID: 9204991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF analysis of IgH gene rearrangement in CNS lymphoma: relationship to the disease course.
    Ekstein D; Ben-Yehuda D; Slyusarevsky E; Lossos A; Linetsky E; Siegal T
    J Neurol Sci; 2006 Aug; 247(1):39-46. PubMed ID: 16678210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
    Della Starza I; Cavalli M; De Novi LA; Genuardi E; Mantoan B; Drandi D; Barbero D; Ciabatti E; Grassi S; Gazzola A; Mannu C; Agostinelli C; Piccaluga PP; Bomben R; Degan M; Gattei V; Guarini A; Foà R; Galimberti S; Ladetto M; Ferrero S; Del Giudice I;
    Hematol Oncol; 2019 Oct; 37(4):368-374. PubMed ID: 31325190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
    Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
    Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
    Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
    Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
    Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
    Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assessment of minimal residual disease in adult patients with B-lineage acute lymphoblastic leukemia using rearranged immunoglobulin loci detection].
    Yao L; Chen ZX; Cen JN; Liu H; He J; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jul; 31(7):433-7. PubMed ID: 21122394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoclonal analysis of immunoglobulin heavy chain and T-cell receptor gamma chain gene rearrangements in paraffin-embedded tissues from non-Hodgkin lymphoma patients].
    Shiozawa E; Yamochi T; Shiozawa T; Yamochi T; Takimoto M; Ota H
    Rinsho Byori; 2007 Aug; 55(8):712-20. PubMed ID: 17882793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplex PCR for the detection of BCL-1/IGH and BCL-2/IGH gene rearrangements--clinical validation in a prospective study of blood and bone marrow in 258 patients with or suspected of non-Hodgkin's lymphoma.
    Nyvold CG; Bendix K; Brandsborg M; Pulczynski S; Silkjaer T; Hokland P
    Acta Oncol; 2007; 46(1):21-30. PubMed ID: 17438702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysis.
    Csinady E; van der Velden VH; Joas R; Fischer S; de Vries JF; Beverloo HB; König M; Pötschger U; van Dongen JJ; Mann G; Haas OA; Panzer-Grümayer ER
    Leukemia; 2009 May; 23(5):870-6. PubMed ID: 19148138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease.
    Andersen NS; Donovan JW; Borus JS; Poor CM; Neuberg D; Aster JC; Nadler LM; Freedman AS; Gribben JG
    Blood; 1997 Nov; 90(10):4212-21. PubMed ID: 9354694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin-embedded tissues.
    Lim LC; Segal GH; Wittwer CT
    Am J Clin Pathol; 1995 Dec; 104(6):689-95. PubMed ID: 8526214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates.
    Engels K; Oeschger S; Hansmann ML; Hillebrand M; Kriener S
    Hum Pathol; 2007 Sep; 38(9):1402-11. PubMed ID: 17560629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.